Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study
Mathilde Lochmann(Centre Léon Bérard), Véronique Christophe(Université Claude Bernard Lyon 1), Françoise Ducimetière(Centre Léon Bérard), Philippe A. Cassier(Lyon College), Aurélie Swalduz(Centre Léon Bérard), Bénédicte Mastroïanni(Centre Léon Bérard), Magali Girodet(Université Claude Bernard Lyon 1), Julie Duranti(Centre Léon Bérard), Mona Amini‐Adlé(Centre Léon Bérard), Armelle Vinceneux(Centre Léon Bérard), Valentine Baudry(Université Claude Bernard Lyon 1), Julien Gautier(Centre Léon Bérard), Gisèle Chvetzoff(Université Claude Bernard Lyon 1), Johanna Despax(Centre Léon Bérard), Mehdi Brahmi(Centre Léon Bérard), Loïc Verlingue(Université Paris-Sud), Hélène Vanacker(Centre Léon Bérard), Olivier Renard(Centre Léon Bérard), Amélie Anota(Centre Léon Bérard)
Cited by 1
Related Papers
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
|Cell Research|2019|246